Indaptus Therapeutics Historical PE Ratio image   This INDP PE ratio history page last updated 4/11/2024
Indaptus Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
3/13/2024
2.00-0.46-1.84NA
Q3 2023
11/6/2023
2.68-0.47-1.88NA
Q2 2023
8/14/2023
2.48-0.39-1.56NA
Q1 2023
5/11/2023
1.95-0.51-2.04NA
Q4 2022
3/17/2023
1.62-0.44-1.76NA
Q3 2022
11/10/2022
1.64-0.42-1.68NA
Q2 2022
8/8/2022
3.31-0.46-1.84NA
Q1 2022
5/12/2022
2.32-0.41-1.64NA
Q4 2021
3/21/2022
3.85-0.22-0.88NA
Q3 2021
11/15/2021
6.75-0.81-3.24NA
Q2 2021
8/16/2021
8.11-5.53-22.12NA
Q1 2021
5/17/2021
3.36-0.96-3.84NA
Q4 2020
3/16/2021
5.07-0.73-2.92NA
Q3 2020
11/5/2020
2.80-0.95-3.80NA
Q2 2020
8/5/2020
0.41-0.05-0.20NA
Q1 2020
5/11/2020
0.23-0.08-0.32NA
Q4 2019
3/13/2020
0.21-0.19-0.76NA
Q3 2019
11/12/2019
0.54-0.61-2.44NA
Q2 2019
8/9/2019
0.46-0.30-1.20NA
Q1 2019
5/7/2019
6.03-0.32-1.28NA
Q4 2018
2/27/2019
8.93-0.38-1.52NA
Q3 2018
11/9/2018
5.89-0.40-1.60NA
Q2 2018
8/15/2018
4.15-0.34-1.36NA
Q1 2018
5/15/2018
4.85-0.40-1.60NA
Q4 2017
3/9/2018
6.60-0.39-1.56NA
Q3 2017
11/15/2017
7.45-0.40-1.60NA
Q1 2017
8/9/2017
5.30-0.41-1.64NA
Q4 2016
4/7/2017
5.40-0.32-1.28NA
Q1 2016
9/1/2016
6.20-0.18-0.72NA
Q4 2015
3/14/2016
4.57-0.26-1.04NA
Q3 2015
11/3/2015
5.89-0.16-0.64NA
Q2 2015
8/5/2015
6.03-0.16-0.64NA
Q1 2015
6/2/2015
NA-0.35-1.40NA
Indaptus Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
3/13/2024
2.00-0.46-1.83NA
Q3 2023
11/6/2023
2.68-0.47-1.81NA
Q2 2023
8/14/2023
2.48-0.39-1.76NA
Q1 2023
5/11/2023
1.95-0.51-1.83NA
Q4 2022
3/17/2023
1.62-0.44-1.73NA
Q3 2022
11/10/2022
1.64-0.42-1.51NA
Q2 2022
8/8/2022
3.31-0.46-1.90NA
Q1 2022
5/12/2022
2.32-0.41-6.97NA
Q4 2021
3/21/2022
3.85-0.22-7.52NA
Q3 2021
11/15/2021
6.75-0.81-8.03NA
Q2 2021
8/16/2021
8.11-5.53-8.17NA
Q1 2021
5/17/2021
3.36-0.96-2.69NA
Q4 2020
3/16/2021
5.07-0.73-1.81NA
Q3 2020
11/5/2020
2.80-0.95-1.27NA
Q2 2020
8/5/2020
0.41-0.05-0.93NA
Q1 2020
5/11/2020
0.23-0.08-1.18NA
Q4 2019
3/13/2020
0.21-0.19-1.42NA
Q3 2019
11/12/2019
0.54-0.61-1.61NA
Q2 2019
8/9/2019
0.46-0.30-1.40NA
Q1 2019
5/7/2019
6.03-0.32-1.44NA
Q4 2018
2/27/2019
8.93-0.38-1.52NA
Q3 2018
11/9/2018
5.89-0.40-1.53NA
Q2 2018
8/15/2018
4.15-0.34-1.53NA
Q1 2018
5/15/2018
4.85-0.40-1.60NA
Q4 2017
3/9/2018
6.60-0.39-1.52NA
Q3 2017
11/15/2017
7.45-0.40-1.31NA
Q1 2017
8/9/2017
5.30-0.41-1.17NA
Q4 2016
4/7/2017
5.40-0.32-0.92NA
Q1 2016
9/1/2016
6.20-0.18-0.76NA
Q4 2015
3/14/2016
4.57-0.26-0.93NA
Q3 2015
11/3/2015
5.89-0.16NANA
Q2 2015
8/5/2015
6.03-0.16NANA
Q1 2015
6/2/2015
NA-0.35NANA
Quotes delayed 20 minutes

Email EnvelopeFree INDP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Indaptus Therapeutics (INDP) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

INFI PE Ratio History
INGN PE Ratio History
INKT PE Ratio History
INMB PE Ratio History
INNV PE Ratio History
INO PE Ratio History
INSM PE Ratio History
INSP PE Ratio History
INTS PE Ratio History
INVA PE Ratio History
How should the INDP historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Indaptus Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this INDP Historical PE Ratio page.

What is the average historical PE for INDP based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The INDP historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for INDP based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The INDP historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Indaptus Therapeutics Historical PE Ratio information for Indaptus Therapeutics' stock. The average INDP historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average INDP historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this INDP historical PE result, against the recent PE: when this page was posted on 4/10/2024, the most recent closing price for INDP had been 2.52, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on INDP or any other given stock, valuation analysis for INDP can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Indaptus Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for INDP. Thanks for visiting, and the next time you need to research INDP Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ETFs Holding ABCO, ICVX Options Chain, BLND Videos.

 

Indaptus Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.